Key Clinical Summary: Coordinating Multidisciplinary Care and Adherence

This is a micro-learning module summary of a presentation by Dr. Craig J. Beavers which you can find here. Before participating, please read our CME and disclosure information which can be found here.

This program is supported by an independent education grant from Bayer. This education program is only available to healthcare professionals in the USA.

Introduction

Effective secondary stroke prevention requires a coordinated, multidisciplinary approach to ensure the safe and timely initiation of antithrombotic therapy. Pharmacists serve as essential collaborators across the entire care continuum, from hospital admission to outpatient follow-up, by providing specialized expertise in medication management and patient education.

The Role of the Pharmacist in Stroke Care

Pharmacists possess a unique skill set that optimizes outcomes for patients with cerebrovascular disease. Their contributions include:

Comprehensive Medication Management: Tailoring drug therapy based on patient-specific factors such as renal function, weight, and potential drug-drug interactions.
Transitions of Care (TOC): Facilitating smooth movement between healthcare settings by performing rigorous medication reconciliation at every entry and exit point.
Protocol Development: Collaborating on facility-specific guidelines and quality improvement initiatives to standardize secondary prevention strategies.

Addressing Barriers to Adherence
Medication non-adherence is a primary driver of recurrent stroke and hospital readmission. Pharmacists identify and mitigate these risks by addressing three core domains:

Socioeconomic Factors: Screening for cost concerns and assisting patients with drug discount programs, generic alternatives, or simplified once-daily dosing regimens.
Communication Barriers: Utilizing interpreters for non-English speakers and employing visual aids or "teach-back" techniques for patients with low health literacy.
Motivation and Perception: Using motivational interviewing to address patient fears and ensuring they understand the specific benefits of their antithrombotic therapy.

Evidence-Based Interventions

Clinical data supports the integration of pharmacists into the stroke care team:

Improved Quality of Life: Pharmacist-led education and follow-up significantly increase treatment adherence scores and improve patient-reported energy and productivity levels.
Targeted Readmission Reduction: While pharmacist-led transitions of care may not reduce all-cause readmissions for every patient, they demonstrate a significant impact in reducing hospital utilization for high-risk subgroups, particularly those with low medication adherence or low health literacy.
Multifaceted Support: Effective programs often include post-discharge calls, 28-day medication supplies, and adherence "pill packs" to bridge the gap between hospital and home.

Clinical Conclusion
The most robust intervention to ensure adherence and safety in secondary stroke prevention is comprehensive patient education combined with scheduled follow-up check-ins. Provider organizations should prioritize pharmacist-led interventions for vulnerable populations, including the elderly and those with complex polypharmacy, to reduce avoidable healthcare utilization and improve long-term outcomes.

Content is accurate as of the date of release on 27 February 2026.